Novel nucleoside-phospholipid conjugate

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 27, 536 28, C07H 1910, C07H 1920, C07D47300

Patent

active

050514997

ABSTRACT:
Novel nucleoside-phospholipid conjugates of the formula ##STR1## wherein R.sub.1 is C.sub.14-24 long chain aliphatic acyl or C.sub.1-24 aliphatic alkyl, R.sub.2 is C.sub.2-10 aliphatic acyl or C.sub.1-24 aliphatic alkyl and N.sub.s is a nucleoside residue; and pharmacologically acceptable salts thereof are prepared in a one-step reaction by reacting the corresponding nucleoside and glycerophospholipid derivative in the presence of phospholipase D-P.

REFERENCES:
patent: 4291024 (1981-09-01), Turcotte
patent: 4797479 (1989-01-01), Shuto
patent: 4921951 (1990-05-01), Shuto
"Phospholipid Derivatives of Necleoside Analogs as Prodrugs with Enhanced Catabolic Stability", Cancer Research, vol. 41, Jul. 1981, by T. Matsushita et al., pp. 2707-2713.
"Cytotoxic Liponucleotide Analogs", Biochimica et Biophysica Acta, 619, 1980, by J. G. Turcotte et al., pp. 619-631.
"Synthesis of Phospholiponucleosides", Synthesis, May 1982, by Fausto Ramirez et al., pp. 402-404.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Novel nucleoside-phospholipid conjugate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel nucleoside-phospholipid conjugate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel nucleoside-phospholipid conjugate will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1697629

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.